BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · Registration - Amendment

FERRING PHARMACEUTICALS - USA

via BUCHANAN INGERSOLL & ROONEY PC

1st Quarter (Jan 1 - Mar 31) · 2013Posted Apr 18, 2013Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: FERRING PHARMACEUTICALS - USA
Location: New York · United States of America

Registrant

Firm: BUCHANAN INGERSOLL & ROONEY PC
Description: law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Health care and pharmaceutical issues.
LobbyistsJON W PLEBANI · mr EDWARD JOHN ALLERA · THEODORE SULLIVAN

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

FERRING PHARMACEUTICALS - USA — Lobbying — Receipts Report